Does it excite you to shape the commercial future of transformative treatments, and do you have experience translating competitive intelligence and data analytics into strategic impact? If this sounds like you, and you are ready to take on a variety of exciting responsibilities, then this could be a great opportunity.
Your new position
As Associate Director, Commercial, you will play a pivotal role in Zealand Pharma's global commercial organization. You will drive commercial efforts specific to competitive intelligence, life cycle management and pipeline evaluation, HCP global engagement strategy, and other related work contributing to Zealand Pharma realizing its ambitions in obesity and metabolic health. Working at the intersection of science, strategy, and stakeholder engagement, this is a high-impact role for a commercially minded professional ready to influence decisions across the organization.
We offer exciting responsibilities:
Your profile
You bring a strategic mindset and a collaborative working style, with the ability to translate complex data and market dynamics into clear commercial implications and direction. You are comfortable engaging with diverse stakeholders — from scientific experts to external partners — and you thrive in a fast-paced, cross-functional environment. You are proactive, structured, and driven by meaningful outcomes.
Your new team
You will join the Commercial function at Zealand Pharma, working closely with commercial colleagues and collaborating across Corporate and Medical CI, New Product Planning, Medical Affairs, Market Analytics, Global Strategy, and Roche/ZP Alliance teams. The role is based in Denmark and sits within a team that is central to shaping how Zealand Pharma brings its innovative metabolic pipeline to patients and healthcare systems worldwide.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation.
Interested in bonding with us ? Then please apply no later than 25 June, or as soon as possible. Applications will be reviewed as they come in. While a cover letter is not required, we would like to understand your motivation for applying.
For further information, please contact VP Commercial, Denise Strauss at DStrauss@zealandpharma.com.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data‑driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma‑invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com

At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other.
Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases.
Our leading obesity programs are backed by strong partners, including Roche and Boehringer Ingelheim.
We are based in Copenhagen (Søborg), Denmark, with a team in the U.S. For further information about our business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.